Kevin Caliendo
Stock Analyst at UBS
(4.17)
# 500
Out of 4,996 analysts
185
Total ratings
67.39%
Success rate
9.02%
Average return
Main Sectors:
Stocks Rated by Kevin Caliendo
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
PINC Premier | Maintains: Neutral | $26 → $28 | $27.81 | +1.58% | 3 | Sep 25, 2025 | |
MCK McKesson | Maintains: Buy | $820 → $860 | $760.55 | +13.08% | 15 | Sep 24, 2025 | |
CVS CVS Health | Upgrades: Buy | $67 → $79 | $75.77 | +4.26% | 9 | Aug 18, 2025 | |
OMI Owens & Minor | Maintains: Buy | $13 → $7 | $4.77 | +46.75% | 6 | Aug 13, 2025 | |
XRAY DENTSPLY SIRONA | Maintains: Buy | $25 → $24 | $12.50 | +92.00% | 11 | Aug 8, 2025 | |
LFST LifeStance Health Group | Maintains: Buy | $8.5 → $9 | $5.42 | +66.05% | 5 | Aug 8, 2025 | |
HSIC Henry Schein | Maintains: Neutral | $75 → $70 | $66.04 | +6.00% | 6 | Aug 6, 2025 | |
NVST Envista Holdings | Maintains: Neutral | $18 → $22 | $20.35 | +8.11% | 4 | Jul 29, 2025 | |
MOH Molina Healthcare | Maintains: Neutral | $260 → $180 | $191.98 | -6.24% | 4 | Jul 25, 2025 | |
LH Labcorp Holdings | Maintains: Buy | $282 → $305 | $280.61 | +8.69% | 5 | Jul 25, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $175 → $180 | $188.99 | -4.76% | 15 | Jul 23, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $400 → $385 | $344.08 | +11.89% | 12 | Jun 25, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $16 → $10 | $18.91 | -47.12% | 1 | May 15, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $6 → $5.25 | $4.04 | +29.95% | 4 | May 13, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $15 | $8.95 | +67.60% | 3 | May 9, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $12 → $9 | $6.20 | +45.16% | 3 | May 8, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $16 → $17 | $17.53 | -3.02% | 7 | May 2, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $160 → $170 | $153.71 | +10.60% | 17 | May 2, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $298 → $335 | $307.00 | +9.12% | 2 | Apr 29, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $240 → $215 | $126.19 | +70.38% | 18 | Apr 24, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $410 → $390 | $286.17 | +36.28% | 11 | Feb 3, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $380 → $250 | $254.95 | -1.94% | 6 | Oct 4, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $72 → $79 | $34.86 | +126.62% | 2 | Dec 21, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $610 → $575 | $318.61 | +80.47% | 1 | Jul 13, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $185 → $180 | $179.71 | +0.16% | 7 | Jul 21, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $130 → $72 | $8.16 | +782.35% | 4 | Mar 8, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $15 → $11 | $18.34 | -40.02% | 4 | May 4, 2021 |
Premier
Sep 25, 2025
Maintains: Neutral
Price Target: $26 → $28
Current: $27.81
Upside: +1.58%
McKesson
Sep 24, 2025
Maintains: Buy
Price Target: $820 → $860
Current: $760.55
Upside: +13.08%
CVS Health
Aug 18, 2025
Upgrades: Buy
Price Target: $67 → $79
Current: $75.77
Upside: +4.26%
Owens & Minor
Aug 13, 2025
Maintains: Buy
Price Target: $13 → $7
Current: $4.77
Upside: +46.75%
DENTSPLY SIRONA
Aug 8, 2025
Maintains: Buy
Price Target: $25 → $24
Current: $12.50
Upside: +92.00%
LifeStance Health Group
Aug 8, 2025
Maintains: Buy
Price Target: $8.5 → $9
Current: $5.42
Upside: +66.05%
Henry Schein
Aug 6, 2025
Maintains: Neutral
Price Target: $75 → $70
Current: $66.04
Upside: +6.00%
Envista Holdings
Jul 29, 2025
Maintains: Neutral
Price Target: $18 → $22
Current: $20.35
Upside: +8.11%
Molina Healthcare
Jul 25, 2025
Maintains: Neutral
Price Target: $260 → $180
Current: $191.98
Upside: -6.24%
Labcorp Holdings
Jul 25, 2025
Maintains: Buy
Price Target: $282 → $305
Current: $280.61
Upside: +8.69%
Jul 23, 2025
Maintains: Neutral
Price Target: $175 → $180
Current: $188.99
Upside: -4.76%
Jun 25, 2025
Maintains: Buy
Price Target: $400 → $385
Current: $344.08
Upside: +11.89%
May 15, 2025
Maintains: Neutral
Price Target: $16 → $10
Current: $18.91
Upside: -47.12%
May 13, 2025
Maintains: Neutral
Price Target: $6 → $5.25
Current: $4.04
Upside: +29.95%
May 9, 2025
Maintains: Buy
Price Target: $14 → $15
Current: $8.95
Upside: +67.60%
May 8, 2025
Maintains: Neutral
Price Target: $12 → $9
Current: $6.20
Upside: +45.16%
May 2, 2025
Maintains: Neutral
Price Target: $16 → $17
Current: $17.53
Upside: -3.02%
May 2, 2025
Maintains: Buy
Price Target: $160 → $170
Current: $153.71
Upside: +10.60%
Apr 29, 2025
Maintains: Buy
Price Target: $298 → $335
Current: $307.00
Upside: +9.12%
Apr 24, 2025
Maintains: Neutral
Price Target: $240 → $215
Current: $126.19
Upside: +70.38%
Feb 3, 2025
Maintains: Buy
Price Target: $410 → $390
Current: $286.17
Upside: +36.28%
Oct 4, 2024
Maintains: Neutral
Price Target: $380 → $250
Current: $254.95
Upside: -1.94%
Dec 21, 2023
Maintains: Neutral
Price Target: $72 → $79
Current: $34.86
Upside: +126.62%
Jul 13, 2023
Maintains: Buy
Price Target: $610 → $575
Current: $318.61
Upside: +80.47%
Jul 21, 2022
Maintains: Neutral
Price Target: $185 → $180
Current: $179.71
Upside: +0.16%
Mar 8, 2022
Maintains: Neutral
Price Target: $130 → $72
Current: $8.16
Upside: +782.35%
May 4, 2021
Downgrades: Neutral
Price Target: $15 → $11
Current: $18.34
Upside: -40.02%